Researcher
Karin Haustermans
- Disciplines:Radiation therapy, Cancer diagnosis, Cancer therapy , Cancer epidemiology
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Responsible
From1 Jan 2012 → Today - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → Today
Projects
1 - 10 of 34 results
- The importance of the TNM Classification for Cancer Surveillance.From20 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Accurate patient-individual prediction of proton therapy benefit in thoracic cancers using 3D dose maps and radiomicsFrom1 Oct 2020 → TodayFunding: FWO junior postdoctoral fellowship
- Characterization of the biological benefits of ultra-high dose rate FLASH proton therapy.From31 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Organ preserving strategies in rectal cancerFrom10 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization of overall treatment time for whole gland stereotactic body radiotherapy with integrated focal boosting in prostate cancerFrom6 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Upgrade of the proton research beam line in the ParTICLe proton therapy center into a high precision proton irradiator.From1 May 2020 → TodayFunding: BOF - scientific equipment program
- Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCsFrom1 Jun 2019 → TodayFunding: H2020 - Euratom
- Extreme hypofractionated radiotherapy with a simultaneously integrated boost to the intraprostatic tumor to improve treatment outcome in prostate cancerFrom1 Jan 2019 → TodayFunding: Foundations, funds and other with scientific goal
- Exploring strategies to reduce toxicity in the multimodal treatment of esophageal cancerFrom1 Jun 2017 → TodayFunding: Nonprofit institution or equivalents
- Translational work on a neoadjuvant combination of chemoradiotherapy and anti-PD-L1 antibody for patients with locally advanced rectal cancerFrom1 Jan 2017 → 31 Dec 2020Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 299 results
- Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.(2021)
Authors: Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, Timothy Price, Ralf D Hofheinz, Bernard Nordlinger, Jean-françois Daisne, Jos Janssens, Baruch Brenner, Hans Reinel, et al.
Pages: 17 - 29 - The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment(2021)
Authors: Melissa Thomas, Robin De Roover, Schalk Van der Merwe, Maarten Lambrecht, Gilles Defraene, Karin Haustermans
Pages: 8 - 14Number of pages: 7 - Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer.(2020)
Authors: Melissa Thomas, Hanna R Mortensen, Lone Hoffmann, Ditte S Møller, Esther GC Troost, Christina T Muijs, Maaike Berbee, Rebecca Bütof, Owen Nicholas, Ganesh Radhakrishna, et al.
Pages: 102 - 112 - Improved repeatability of dynamic contrastenhanced MRI using the complex MRI signal to derive arterial input functions: a test-retest study in prostate cancer patients (vol 81, pg 3358, 2019)(2020)
Authors: Edzo ME Klawer, Petra J van Houdt, Frank FJ Simonis, Cornelis AT van den Berg, Floris J Pos, Stijn WTPJ Heijmink, Sofie Isebaert, Karin Haustermans, Uulke A van der Heide
Pages: 2334 - 2336Number of pages: 3 - Dosimetric impact of intrafraction prostate rotation and accuracy of gating, multi-leaf collimator tracking and couch tracking to manage rotation: An end-to-end validation using volumetric film measurements.(2020)
Authors: Robin De Roover, Rune Hansen, Wouter Crijns, Casper Gammelmark Muurholm, Kenneth Poels, Simon Skouboe, Karin Haustermans, Per Rugaard Poulsen, Tom Depuydt
Pages: 10 - 18 - The Treasury of Images: exploring the opportunities for diagnosing and treating prostate cancer(2020)
Authors: Cédric Draulans, Karin Haustermans, Frederik Maes, Sofie Isebaert
- Knowledge-Based Assessment of Focal Dose Escalation Treatment Plans in Prostate Cancer(2020)
Authors: Marcel A van Schie, Tomas M Janssen, Dave Eekhout, Iris Walraven, Floris J Pos, Peter de Ruiter, Alexis NTJ Kotte, Evelyn M Monninkhof, Linda GW Kerkmeijer, Cédric Draulans, et al.
Pages: 1055 - 1062Number of pages: 8 - Exploring strategies to reduce toxicity in the multimodal treatment of oesophageal cancer(2020)
Authors: Melissa Thomas, Karin Haustermans, Philippe Nafteux, Maarten Lambrecht
- Radiotherapie bij primaire prostaatkanker: als minder meer wordt(2020)
Authors: Cédric Draulans, Charlien Berghen, Gert De Meerleer, Steven Joniau, Sofie Isebaert, Karin Haustermans
Pages: 1098 - 1106 - A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort(2020)
Authors: Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, Anna Maria Paganoni, Paolo Zunino, Andrea Manzoni, Nicola Rares Franco, Liv Veldeman, Piet Ost, Valerie Fonteyne, et al.
Number of pages: 15